natgillin/translations-raw huggingface dataset:
poudarja, da so krepitev načel pravne države in notranje reforme, vključno z verodostojnim bojem proti korupciji, bistvene ne le za sklenitev in ratifikacijo pridružitvenega sporazuma in poglobitev odnosov med EU in Ukrajino, temveč tudi za utrditev demokracije v Ukrajini;
Stresses that the strengthening of the rule of law and internal reform, including a credible fight against corruption, are essential not only for the conclusion and ratification of the Association Agreement and the deepening of EU-Ukraine relations, but also for the consolidation of democracy in Ukraine;
pozdravlja doseženi dogovor o poglobljenem in celovitem območju proste trgovine; meni, da je ta sporazum trdna osnova za morebitno končanje pogajanj o pridružitvenem sporazumu med Evropsko unijo in Ukrajino;
Welcomes the agreement that has been reached on a Deep and Comprehensive Free Trade Area ; regards this agreement as a solid basis for the possible finalisation of the negotiations on an Association Agreement between the European Union and Ukraine;
je zaskrbljen zaradi poročil o slabšanju medijske svobode in pluralizma o Ukrajini; poziva oblasti, naj sprejmejo vse potrebne ukrepe za zaščito teh bistvenih vidikov demokratične družbe ter se vzdržijo vseh poskusov neposrednega ali posrednega nadzora vsebine poročanja nacionalnih medijev;
Expresses alarm at reports concerning the deterioration of media freedom and pluralism in Ukraine; calls on the authorities to take all necessary measures to protect these essential aspects of a democratic society and to refrain from any attempt to control, directly or indirectly, the content of national media reporting;
odločno podpira priporočila o predlogu zakona o parlamentarnih volitvah, predstavljena v skupnem mnenju Beneške komisije in OVSE/ODIHR; meni, da je treba ta priporočila hitro, vključujoče in celovito sprejeti in izvajati, v kar je treba vključiti tako opozicijo kot civilno družbo;
Strongly supports the recommendations put forward in the joint opinion of the Venice Commission and the OSCE/ODIHR on the draft parliamentary election law; considers it essential that these recommendations should be adopted and implemented in an expedient, inclusive and comprehensive fashion, involving both the opposition and civil society;
odločno poziva vse politične sile v Ukrajini, naj opravijo pravično in pregledno razpravo o procesu sprejemanja političnih odločitev; vztraja, da mora parlamentarni preiskovalni odbor opraviti preiskavo o morebitnem nepravilnem izvajanju tega postopka;
Urges all political forces in Ukraine to conduct a fair and transparent debate about the political decision-making process; insists that investigations into possible failures in that process should be carried out by a parliamentary committee of inquiry;
meni, da bi bilo nedavno preloženo srečanje s predsednikom Janukovičem pomembna priložnost za obravnavanje resnih pomislekov, naslovljenih na ukrajinsko vlado, in za ponovno vzpostavitev konstruktivnega dialoga, ki bi lahko pripomogel k parafiranju pridružitvenega sporazuma, če bo dosežen dovolj velik napredek pri odstranjevanju tehničnih in ključnih političnih ovir, ki še obstajajo; poziva Svet in Komisijo, naj določita nov datum za srečanje s predsednikom Janukovičem, da bo potekalo pred načrtovanim vrhunskim srečanjem med EU in Ukrajino decembra 2011;
Considers that the recently postponed meeting with President Yanukovych would have offered an excellent opportunity to tackle serious concerns which have been addressed to the Ukraine Government and re-establish a constructive dialogue that could lead to the initialling of the Association Agreement, provided that significant progress is made on the remaining technical and key political obstacles; calls on the Council and Commission to reschedule the meeting with President Yanukovych so that it takes place ahead of the planned EU-Ukraine Summit in December 2011;
poziva Komisijo, naj z boljšo uporabo programa EU za izgradnjo zmogljivosti pomaga pri reformi sodstva v Ukrajini in naj preuči ustanovitev svetovalne skupine EU na visoki ravni za Ukrajino, da bi ji pomagala pri prizadevanjih za uskladitev njene zakonodaje z zakonodajo EU, tudi na področju sodstva;
Calls on the Commission to support judicial reform in Ukraine by making better use of the EU's capacity-building programme and to consider setting up a High-Level EU Advisory Group to assist Ukraine in its efforts to fall into line with EU legislation, including in the judicial sphere;
naroči svojemu predsedniku, naj to resolucijo posreduje Svetu, Komisiji, podpredsednici Komisije/visoki predstavnici Unije za zunanje zadeve in varnostno politiko, vladam in parlamentom držav članic, vladi in parlamentu Ukrajine ter parlamentarnim skupščinam Sveta Evrope in Organizacije za varnost in sodelovanje v Evropi.
Instructs its President to forward this resolution to the Council, the Commission, the Vice-President of the Commission/High Representative of the Union for Foreign Affairs and Security Policy, the governments and parliaments of the Member States, the Government and Parliament of Ukraine and the Parliamentary Assemblies of the Council of Europe and the OSCE.
ob upoštevanju svoje resolucije z dne 12. maja 2011 o odpornosti na antibiotike, ki se osredotoča na zdravje živali,
having regard to its resolution of 12 May 2011 on antibiotic resistance, focusing on animal health,
ob upoštevanju znanstvenega mnenja Evropske agencije za varno hrano (EFSA) o zdravstvenih tveganjih bakterijskih sevov, ki proizvajajo betalaktamaze razširjenega spektra in/ali betalaktamaze AmpC v hrani in živalih, namenjenih prehrani ljudi, iz avgusta 2011,
having regard to the European Food Safety Authority (EFSA) Scientific Opinion ‘on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals’ of August 2011,
ob upoštevanju delovnega dokumenta služb Komisije z dne 18. novembra 2009 o odpornosti na antibiotike (SANCO/6876/2009r6),
having regard to the Staff working paper of the services of the Commission on antimicrobial resistance of 18 November 2009 (SANCO/6876/2009r6),
ob upoštevanju skupnega tehničnega poročila Evropskega centra za preprečevanje in nadzor bolezni in Evropske agencije za zdravila iz septembra 2009 naslovom Bakterije so izziv: čas je za ukrepanje – poziv k zmanjšanju razkoraka med pojavom večkratno odpornih bakterij v EU in razvojem novih protibakterijskih sredstev,
having regard to the Joint Technical Report by the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) of September 2009 on ‘The bacterial challenge: time to react - A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents’,
ob upoštevanju priporočila Sveta z dne 15. novembra 2001 o preudarni uporabi protimikrobnih sredstev v humani medicini (2002/77/ES) in resolucije Evropskega parlamenta z dne 23. oktober 2001 o predlogu tega priporočila Sveta (KOM (2001)0333- C5-0411/2001 - 2001/2164(COS) ),
having regard to the Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC) and the European Parliament resolution of 23 October 2001 on the proposal for this Council Recommendation (COM(2001)333 - C5-0411/2001 - 2001/2164(COS) ),
ob upoštevanju sporočila Komisije z dne 20. junija 2001 o strategiji Skupnosti za boj proti protimikrobni odpornosti ( KOM(2001)0333 ),
having regard to the Commission Communication of 20 June 2001 on a Community Strategy against antimicrobial resistance ( COM(2001)0333 ),
ker protimikrobna sredstva lahko uničijo ali zavrejo rast bakterij, virusov in drugih mikroorganizmov (antibiotiki so mikrobna sredstva, ki delujejo zgolj na bakterije) in imajo zato pomembno vlogo pri izboljševanju javnega zdravja, saj pripomorejo k zmanjševanju števila smrti zaradi bolezni in okužb, ki so bile prej neozdravljive ali smrtne;
whereas antimicrobial agents are able to destroy or prevent the growth of bacteria, viruses and other micro-organisms (antibiotics are microbial agents which only react against bacteria) and thereby have played a significant role in improving public health by helping to reduce the number of deaths from diseases and infections which were previously incurable or fatal;
ker so nekateri mikroorganizmi, ki so bili prej občutljivi na ta protimikrobna sredstva, zaradi njihove uporabe razvili tako imenovano protimikrobno odpornost;
whereas their use has resulted in certain micro-organisms previously sensitive to these antimicrobial agents developing so-called ‘antimicrobial resistance’;
ker pretirana in nenadzorovana uporaba teh protimikrobnih sredstev pospešuje ta naravni proces, s tem pa je ogrožen doseženi medicinski napredek;
whereas this natural process is accelerated by the excessive and uncontrolled use of these antimicrobial agents, thereby jeopardizing the medical successes achieved;
ker se vsakič, ko se začne uporabljati nov antibiotik, pojavi odpornost pri ciljni bakteriji; ker je za vzdrževanje učinkovitih zmogljivosti boja proti nalezljivim boleznim potreben razvoj novih protimikrobnih sredstev in boljše ohranjanje obstoječih antibiotičnih virov, zato poudarja, da je prednostna naloga zagotoviti učinkovito in omejeno uporabo antibiotikov samo za nujno zdravljenje;
whereas the launch of every new antibiotic has been, and will be, followed by resistance in the targeted bacteria; whereas the maintenance of an effective capacity to combat infectious disease requires both the development of new antimicrobial agents and improved conservation of existing antibiotic resources, thus underlining the priority of ensuring that the use of antibiotics is effectively controlled and limited to necessary treatment only;
ker je farmacevtska industrija približno štiri desetletja (od 40-ih do 70-ih let prejšnjega stoletja) zagotavljala reden dotok novih antibiotikov, tudi številne z novimi mehanizmi delovanja, s katerimi so zaobšli težave, ki jih je povzročala odpornost na zgodnejša sredstva; ker je bilo od tedaj razvitih in odobrenih samo nekaj novih protimikrobnih sredstev;
whereas for approximately four decades (from the 1940s to the 1970s) the pharmaceutical industry provided a steady flow of new antibiotics, including several with new mechanisms of action that circumvented the problems caused by resistance to earlier agents; whereas only a few new antimicrobials have been developed and authorised since then;
ker je protimikrobna odpornost pomembno in pretežno nerešeno vprašanje, ki ogroža javno zdravje v Evropi in po svetu, saj povzroča, da je zdravljenje daljše in bolj zapleteno, zmanjšuje kakovost življenja, povečuje nevarnost smrti (vsako leto v EU umre 25.000 bolnikov zaradi okužb, ki jih povzročijo odporni mikroorganizmi), povzroča dodatne stroški zdravstvenega varstva in izgubo produktivnosti v višini vsaj 1.5 milijarde evrov letno;
whereas antimicrobial resistance is an important, largely unresolved, issue which has become a threat to public health in Europe and globally, resulting in longer, more complicated treatments, a diminution of quality of life, a greater risk of deaths (25 000 patients die each year in the EU from an infection caused by resistant micro-organisms), extra healthcare costs and productivity losses of at least EUR 1.5 billion per year;
ker velik delež okužb v bolnišnicah povzročijo močno odporne bakterije, kakršna sta proti meticilinu odporna Staphylococcus aureus (MRSA) in C. difficile, kar resno ogroža varnost bolnikov;
whereas a high percentage of hospital-acquired infections are caused by highly resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and C. difficile, constituting a serious risk to patient safety;
ker je protimikrobna odpornost postala tako pomembno vprašanje, da jo je Svetovna zdravstvena organizacija vzela za temo letošnjega svetovnega dneva zdravja 7. aprila, in ker Evropska unija od leta 2008 vsako leto 18. novembra organizira evropski dan ozaveščanja o antibiotikih;
whereas antimicrobial resistance has become such a critical issue that the World Health Organization made it the theme of this year's World Health Day on 7 April and that the European Union has since 2008 organised an annual European Antibiotic Awareness Day on 18 November;
ker neustrezna in nesmotrna uporaba protimikrobnih zdravil povzroča ugodne pogoje za pojav, širjenje in obstojnost odpornih mikroorganizmov;
whereas inappropriate and irrational use of antimicrobial medicines provides favourable conditions for resistant microorganisms to emerge, spread and persist;
ker protimikrobno odpornost pri ljudeh pogosto povzročijo neustrezni odmerki antibiotikov, nepravilno zdravljenje in stalna izpostavljenost patogenov protimikrobnim zdravilom v bolnišnicah;
whereas antimicrobial resistance in humans is often caused by inadequate doses of antibiotic medicines, by incorrect treatments and through the constant exposure of pathogens to antimicrobial agents in hospitals;
ker lahko dobra higiena v obliki učinkovitega umivanja in sušenja rok pripomore k zmanjšanju potrebe po antibiotikih ter protimikrobnih sredstvih;
whereas good hygiene in the form of effective hand washing and hand drying can help reduce the need for antibiotics and antimicrobial agents;
ker kljub prepovedi uporabe antibiotikov kot pospeševalcev rasti in želje po zmanjšanju potrošnje antibiotikov v neustrezne preventivne namene odpornost na protimikrobna zdravila vpliva na ljudi in na živali in je prenosljiva v obe smeri, zaradi česar je to resnično horizontalno vprašanje, za katerega je potreben usklajen pristop na ravni Unije; ker so zato potrebna dodatna prizadevanja za izboljšanje kmetijskih praks, s čimer bi pripomogli k zmanjšanju tveganja, povezanega z uporabo antibiotikov v veterinarske namene in razvojem odpornosti pri človeku;
whereas, despite the ban on the use of antibiotics as growth promoters and the will to decrease veterinary consumption of antibiotics for inappropriate ‘prophylactic’ purposes, antimicrobial resistance affects both humans and animals and may potentially be transmitted both ways, making this a truly cross-cutting matter which calls for a coordinated approach at Union level; whereas additional efforts are therefore required to improve agricultural practices so as to help minimise the risk associated with the use of antibiotics for veterinary purposes and the development of resistance in humans;
ker dobra rejska praksa zmanjša potrebe po antibiotikih;
whereas good husbandry minimises the need for antibiotics;
ker ukrepi proti odpornosti na protimikrobna sredstva v humani medicini ne morejo potekati ločeno od ukrepov za boj proti odpornosti na protimikrobna sredstva v veterinarski medicini, živalski krmi in pri pridelavi poljščin;
whereas action against resistance to antimicrobial agents in human medicines cannot therefore be taken in isolation from measures to combat resistance to antimicrobial agents in veterinary medicines, animal feeding stuffs and crop-growing;
ker obstaja evropska pobuda EPRUMA Evropska platforma za odgovorno uporabo zdravil pri živalih.
whereas EPRUMA European Platform for the Responsible Use of Medicines in Animals.
ker je protimikrobna odpornost pojav, ki ima očitno čezmejne posledice in ker ne moremo izključiti možnosti izjemnega dogodka, ki ga najverjetneje ne bi bilo možno nadzorovati s sedanjimi sredstvi in znanjem, imel pa bi lahko nepredvidljive zdravstvene, družbene in gospodarske posledice;
whereas antimicrobial resistance is a phenomenon which clearly has cross-border implications and the occurrence of an outlier effect, which would most probably not be manageable with the current resources and knowledge, cannot be excluded and can have unpredictable medical, social and economic setbacks;
je seznanjen z zaskrbljenostjo, da protimikrobna odpornosti vse bolj ogroža javno zdravje v Evropi in po svetu, kljub ukrepom, ki so bili sprejeti na evropski in mednarodni ravni;
Notes with concern that antimicrobial resistance is an ever increasing threat to public health in Europe and worldwide, despite the actions taken at European and international level;
poziva k nadaljnji okrepitvi boja proti odpornosti na protimikrobna sredstva v humani medicini, pri čemer se je treba v naslednjem prednostnem redu osredotočiti na:
Calls for a further intensification of the fight against resistance to antimicrobial agents in human medicines, focusing on, in the following order of priority:
preudarno uporabo protimikrobnih sredstev za ljudi in živali, ob zagotavljanju, da se jih uporablja samo, kadar so res potrebna za dejansko zdravljenje bolezni, ob pravem odmerku, presledkih med odmerki in trajanju dajanja sredstva,
the prudent use of antimicrobial agents both for humans and for animals, ensuring that they are only used when effectively needed for actual treatment of disease, with the correct dosage, dose intervals and duration,
nadzor in spremljanje protimikrobne odpornosti,
the monitoring and surveillance of antimicrobial resistance,
potrebo po raziskavah in razvoju novih protimikrobnih sredstev in njihovih alternativ,
the need for research into, and the development of, new antimicrobial agents and alternatives,
povezavo z ukrepi za boj proti odpornosti na protimikrobna sredstva v veterinarski medicini, živalski krmi in pri pridelavi poljščin;
links with measures to combat resistance to antimicrobial agents in veterinary medicines, animal feeding stuffs and crop-growing;
poziva Komisijo, naj nemudoma predlaga zakonodajni okvir za ukrepanje proti protimikrobni odpornosti, in sicer s promocijo pobud za odgovorno uporabo ter podpiranjem širjenja takih pobud in obveščanja o njih;
Calls on the Commission to propose without delay a legislative framework for action against antimicrobial resistance, by promoting ‘responsible use’ initiatives and supporting dissemination of, and information about, such initiatives;
znova poudarja, da je nujno treba ukrepati, da se izognemo nadaljnjemu povečevanju odpornosti mikrorganizmov ali ga celo zaustavimo s tem, da zmanjšamo nepotrebno in neustrezno uporabo protimikrobnih sredstev;
Reconfirms that urgent action is necessary to avoid, or even reverse, further increases in resistant micro-organisms by reducing unnecessary and inappropriate use of antimicrobial agents;
je seznanjen, da sta poročilo Komisije o izvajanju priporočila Sveta iz leta 2001 Delovni dokument osebja Komisije; spremljevalni dokument drugega poročila Komisije in Sveta na podlagi poročil držav članic o izvajanju priporočila Sveta (2002/777/ES) o preudarni uporabi protimikrobnih sredstev v humani medicini
Notes that a Commission Report on the implementation of the 2001 Council Recommendation Commission Staff Working Document , Accompanying document to the second report from the Commission to the Council on the basis of Member States' reports on the implementation of the Council Recommendation (2002/777/EC) on the prudent use of antimicrobial agents in human medicine.
in raziskava Eurobarometra iz leta 2010 ugotovila niz pomanjkljivosti ter vrzeli pri spodbujanju preudarne uporabe protimikrobnih sredstev;
and the 2010 Eurobarometer survey identified a series of shortfalls and gaps in the promotion of the prudent use of antimicrobial resistance;
je seznanjen, da je dostop do informacij o protimikrobni odpornosti in posledicah potrošniškega obnašanja državljanov še vedno neenak po Uniji, zlasti glede izvrševanja zakonodaje o uporabi antibiotikov samo na zdravniški recept, saj je odstotek antibiotikov, ki so bili 2008 prodani brez zdravniškega recepta, kazal na znatne razlike med državami članicami;
Notes that the level of access to information on antimicrobial resistance and the impact on the consumption behaviour of citizens remain uneven across the Union, in particular with regard to the enforcement of the legislation on prescription-only use for antibiotics, as the percentage of antibiotics sold without prescription in 2008 showed considerable differences between Member States;
ugotavlja, da je Evropa toliko ranljiva, kolikor je ranljiv njen najšibkejši člen, zato je treba posebno pozorno ravnati v državah z izrazito visoko stopnjo protimikrobne odpornosti;
Notes in this respect that Europe is as weak as the weakest link, therefore particular attention should be paid in countries with high levels of antimicrobial resistance;
poziva Komisijo, naj dodatno razvije priporočila Sveta z dne 15. novembra 2001 in pripravi predloge za znatno zmanjšanje uporabe antibiotikov ter za opredelitev in določitev splošnih načel in primerov najboljše prakse pri uporabi protimikrobnih sredstev ter zagotovi, da bodo ta načela in metode ustrezno izvajani v Evropski uniji;
Calls on the Commission to come forward with proposals to significantly reduce the use of antibiotics and to identify and define general principles and best practices on the prudent use of antimicrobial agents, further elaborating on the Council Recommendation of 15 November 2001, and to ensure that these principles and methods are properly implemented in the European Union;
priznava, da o antibiotikih in njihovi učinkih obstaja veliko napačnih predstav in da naj bi po raziskavi Komisije 53 % Evropejcev še vedno verjelo, da antibiotiki ubijejo viruse, 47 % pa, da so učinkoviti zoper prehlad in gripo (posebni Evrobarometer št. 338 o protimikrobni odpornosti, april 2010),
Recognises that many misconceptions exist about antibiotics and their effects, and that according to a survey commissioned by the Commission 53% of Europeans still believe that antibiotics kill viruses and 47% believe that they are effective against colds and flu (Special Eurobarometer 338 on Antimicrobial Resistance, April 2010);
ugotavlja, da če pacienti ne upoštevajo navodil, na primer ne dokončajo celega zdravljenja ali ne sledijo priporočilom o doziranju, to močno prispeva k protimikrobni odpornosti;
Recognises that patients' lack of adherence to and compliance with prescriptions, such as failing to complete the course of treatment or not following the dosage recommendations, contributes heavily to antimicrobial resistance;
poziva Komisijo, naj preuči vprašanje neustrezne uporabe in prodaje protimikrobnih sredstev na zdravniški recept ali brez njega z vidika obnašanja vseh udeležencev skozi celotno verigo, od zdravnika in lekarnarja do bolnika, ter izvaja celovito dolgoročno strategijo ozaveščanja vseh udeleženih;
Calls on the Commission to study the issue of inappropriate use and sales of antimicrobial agents with or without prescription throughout the chain – from the doctor and the pharmacist to the patient – in terms of the behaviour of all actors involved, and to implement a comprehensive long-term strategy on the awareness of all these actors;
poudarja, da je treba v okviru preudarne rabe protimikrobnih sredstev posvetiti pozornost tudi temu, da zadevni akterji bolje uporabljajo razpoložljive antibiotike, in sicer da natančno preučijo doziranje, trajanje zdravljenja in kombinacijo zdravil;
Emphasises the fact that in ensuring the prudent use of antimicrobial agents, attention needs to be paid by the relevant actors to the better use of antibiotics currently available by means of a close examination of the dosage, treatment duration and drug combination;
poziva Komisijo in države članice, naj spodbujajo temeljito umivanje in sušenje rok, zlasti v bolnišnicah, da bi preprečile širjenje okužb in zmanjšale potrebo po antibiotikih;
Calls on the Commission and Member States to promote good hand washing and hand drying - especially in hospitals - in order to prevent the spread of infections and reduce the need for antibiotics;
zato pozdravlja evropski dan ozaveščanja o antibiotikih, ki je vsako leto 18. novembra in je namenjen ozaveščanju o nevarnosti protimikrobne odpornosti za javno zdravje ter z več ukrepi v državah članicah poziva k odgovornejši uporabi antibiotikov;
Welcomes therefore the annual European Antibiotic Awareness Day on 18 November which aims to raise awareness of the public health threat of antimicrobial resistance and call for more responsible use of antibiotics by multiple actions in Member States;